ArticleCardiovascular diabetology2014

The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK- and MAPK-dependent mechanisms.

Yanmei Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.